Johnson & Johnson Health Care Systems Inc
Johnson & Johnson Patient Assistance Program
Information last checked August 26, 2026
Contact info
- Phone
- 1-833-742-0791
Eligibility
- Patient must be uninsured or have inadequate coverage through commercial, employer group, or government insurance coverage.
- Patients with Medicare Part D must spend 4% of gross annual household income on out-of-pocket prescription costs for yourself and/or other household members.
- Income limit, single
- Not published
- Income limit, couple
- Not published
- Medical expenses can be deducted
- Not published
- Social Security number asked for
- No
- US citizenship or residency required
- Yes
Not sure where your income falls? See this year's federal poverty guidelines (opens in a new tab).
Application process
- Documents to attach
- Proof of income
- Prescriber license number
- NPI number
- Both DEA and state license numbers
- Who can sign
- Physician
- Application can be faxed
- Yes
- Decision letter sent to
- Provider and patient
Getting the medication
- Patient receives
- Medication
- Shipped to
- Provider or patient
- Supply per shipment
- Not published
- Time to first delivery
- Not published
- Refills
- Not published
- Staying enrolled
- New application every 12 months
- New proof of income every 12 months
Medications covered
- Akeega (niraparib and abiraterone acetate)
- Balversa (erdafitinib)
- Darzalex (daratumumab)
- Darzelex Faspro (daratumumab and hyaluronidase-fihj, Injection for subcutaneous use)
- Edurant (rilpivirne)
- Elmiron (pentosan polysulfate sodium)
- Erleada Tablets (apalutamide)
- Inlexzo (gemcitabine intravesical system)
- Intelence (etravirine)
- Invega Hafyera (paliperidone palmitate)
- Invega Sustenna (paliperidone palmitate)
- Invega Trinza (paliperidone palmitate)
- Invokamet (canagliflozin-metformin)
- Invokamet XR (canagliflozin/metformin HCI)
- Invokana (canagliflozin)
- Prezcobix Tablets (darunavir/cobicistat)
- Prezista (darunavir)
- Risperdal Consta (risperidone)
- Rybrevant (amivantamab-vmjw)
- Rybrevant in combination with Lazcluze (amivantamab-vmjw and lazertinib)
- Sirturo Tablets (bedaquiline)
- Spravato (esketamine)
- Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide)
- Talvey (talquetamab-tgvs)
- Tecvayli (teclistamab-cqyv)
- Xarelto (rivaroxaban tablets)
- Yondelis (trabectedin)